APR Refutes Medicube’s "Sudan Red Detection"... "Never Officially Exported"

Neither the HSA-identified Batches nor Sellers Found in Official Distribution Channels
Distribution Routes Under Investigation, Including Possibility of Counterfeits
No Sudan Red Detected in Separate Inspection

APR has refuted the announcement by Singapore’s Health Sciences Authority (HSA) that trace amounts of Sudan Red were detected in some batches of Medicube’s "PDRN Pink Collagen Capsule Cream," emphasizing that the products in question were not exported to Singapore via the company’s official distribution network.

According to APR on September 3, the batch numbers cited by the HSA regarding the detected Sudan Red are ‘2E122I·2E117I’ and ‘2E191G·2E193G’. After verifying the official shipping and export records, the company confirmed there is no record of these batches having been exported to Singapore.

Images of key products from Medicube Cosmetics and Medicube AGR. APR

In particular, Venus Beauty Pte. Ltd., a local company identified as the distributor of the sample analyzed by the HSA, was also confirmed not to be an official supplier or distributor of APR. APR stated that it has never directly supplied or exported the relevant products to Venus Beauty.

Industry insiders have also raised questions about the authenticity of the products tested by the HSA. With the overseas popularity of K-beauty brands such as Medicube on the rise, concerns have intensified about counterfeit versions of popular brands circulating internationally, further highlighting the need to clarify the distribution channels, especially as it is now established that these products were sold outside official networks.

However, APR is not concluding at this stage that the products in question are counterfeit. The company is currently investigating both the authenticity of the products and the specific local distribution routes.

APR explained that a separate inspection conducted at the request of the HSA detected no Sudan Red. The company had its products tested by an HSA-accredited laboratory in Singapore on August 3, and after receiving results showing no detection, APR was notified by the HSA on August 26 that the sales and supply suspension was lifted.

An APR representative stated, "The distributor of the sample with the detected Sudan Red is not an official distributor of ours, and the relevant batches are also not listed in official export records to Singapore. We are verifying the facts objectively, based on available data, to determine the precise route by which the products were distributed locally."

The representative added, "We will continue to place the highest priority on product quality and safety, carefully checking relevant testing and distribution records, while maintaining close communication with the authorities."

This content was produced with the assistance of AI translation services.